
    
      The total duration of study per patient is up to 8 weeks with 3 to 28 days screening period,
      1 day for treatment for both periods and 7 to 14 days wash out between 2 administrations, and
      7 days (+/- 1 day) follow-up after last IMP administration.
    
  